Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
نویسندگان
چکیده
Multitransfused recipients of random donor platelet concentrates frequently form broadly-reactive human leukocyte antigen (HLA) antibodies which restrict the pool of suitable donors to those who are HLA matched with the recipient. In an effort to expand the donor pool for such patients, a retrospective analysis of the antibodies formed by alloimmunized recipients was performed taking sensitization to public HLA antigens into account. A total of 144 sera from 18 subjects was analyzed. Peak reactive sera from these patients ranged from 53 to 100 percent when tested against lymphocyte panels. When the reaction patterns of these sera were evaluated, 11 patients formed antibodies against public antigens only, three patients formed antibodies reacting exclusively with private determinants, and two patients formed antibodies reacting with both public and private antigens. The specificities in highly reactive sera from two patients could not be identified. A total of 153 lymphocyte crossmatches was performed while these patients were receiving single donor HLA-matched platelets. Forty-six positive crossmatches were obtained of which 33 occurred with donors mismatched for at least one non-crossreactive HLA antigen with the recipient. Of these, 26/33 (79 percent) positive crossmatches were predicted by the results of the serum analysis for antibodies directed against public HLA determinants. Similarly, 31/40 (78 percent) negative lymphocyte crossmatches were predictable on the basis of the serum analysis. It is concluded that "multispecific" lymphocytotoxic antibodies formed by multitransfused recipients of platelet concentrates, are often directed against one or a few public HLA determinants.(ABSTRACT TRUNCATED AT 250 WORDS)
منابع مشابه
Platelet antigens and antibodies in multitransfused patients
Abstract Background and Objectives Following incompatible blood transfusions, anti-HLA and anti- HPA antibodies may develop and cause various disorders such as post-transfusion purpura, platelet refractoriness, and thrombocytopenia leading to bleeding. The aim of this study was to investigate platelet antigens and antibodies in multi-transfused patients. Materials and Methods In this desc...
متن کاملAntibodies against human platelet alloantigens and human leucocyte antigen class 1 in Saudi Arabian multiparous women and multi-transfused patients
OBJECTIVES To determine the frequency of alloimmunization against human platelet antigens (HPAs) and human leucocyte antigen class 1 (HLA1) in multiparous women and multi-transfused patients. METHODS This prospective study was conducted between January and August 2013, on 50 multiparous women with no history of previous blood transfusion recruited from the Obstetrics and Gynecology Clinic, ...
متن کاملAlloimmunization to platelets in heavily transfused patients with sickle cell disease.
Bone marrow transplantation (BMT) is now an option for some patients with sickle cell disease (SCD). Many SCD patients are multiply transfused with red blood cells (RBCs), and may be immunized to alloantigens other than erythrocyte antigens. Because platelet refractoriness is a significant complication during BMT, we wished to determine the prevalence of alloimmunization to platelets in transfu...
متن کاملPlatelet Refractoriness and how it is formed
Abstract Background and Objectives Transfusion of platelet has become one of the main treatments for thrombocytopenic patients to reduce the severity and frequency of bleeding consequences. Failure to attain the desired level of platelets in a patient following platelet transfusion is defined as platelet refractoriness. The purpose of present paper is to review and study the mechanisms involve...
متن کاملHLA alloimmunization and blood requirements in orthotopic liver transplantation.
ORTHOTOPIC LIVER transplantation (OL T) is often accompanied by massive blood loss due to portal hypertension, difficult dissection as a result of previous abdominal surgery. and coagulation abnormalities. Major alterations of the coagulation factors such as prolonged prothrombin time (PT) and activated partial thromboplastin time (APTT). decreased fibrinogen levels and thrombocytopenia have al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of clinical and laboratory science
دوره 16 1 شماره
صفحات -
تاریخ انتشار 1986